Michael Chuong, Chief of GI Radiation Oncology at Miami Cancer Institute, shared a post on X:
“First patterns of failure outcomes after definitive 5-fraction ablative radiation therapy for locally advanced pancreatic cancer.
I think both dose escalation and comprehensive elective coverage are key to achieving durable locoregional control.”
Drew Moghanaki, Professor, Chief of Thoracic Oncology at the Department of Radiation Oncology and Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at David Geffen School of Medicine at UCLA, and Chief Medical Officer of Respirati, shared the post, adding:
“I’ll say it again. I just can’t envision the outcomes after a Whipple resection being any better in a RCT vs. full-dose SBRT, which can only be delivered safely with MRgRT.”
Title: Patterns of failure after definitive ablative 5-fraction stereotactic body radiation therapy for inoperable pancreatic ductal adenocarcinoma
Authors: Michael Chuong, Roberto Herrera, Jason Extein, Surya Chundru, Nicole Luther, Kathryn Mittauer, Mukesh Roy, Nicolas Carvallo, Rupesh Kotecha, Matthew Hall, Yongsook Lee, Tatiana Bejarano, Nema Bassiri, Alonso Gutierrez, Ranjini Tolakanahalli, Antonio Ucar, Fernando DeZarraga, Santiago Aparo, Minesh Mehta, Adeel Kaiser
Other articles featuring Drew Moghanaki and Michael Chuong on OncoDaily.